Navigation Links
FDA Advisory Committee Recommends Approval of Abbott's XIENCE(TM) V Drug Eluting Stent System
Date:11/29/2007

ABBOTT PARK, Ill., Nov. 29 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT)announced today that the Circulatory System Devices Advisory Panel to the U.S. Food and Drug Administration (FDA) recommended approval for the XIENCE(TM) V Everolimus Eluting Coronary Stent System. XIENCE V is a next-generation drug eluting stent intended for use in the treatment of coronary artery disease.

The FDA advisory committee voted to recommend the XIENCE V stent system for approval with conditions related to post-marketing study requirements and language related to dual antiplatelet therapy. The FDA is not required to, but usually follows the recommendations of its advisory committees.

"The clinical and angiographic benefits of the XIENCE V stent compared to the most widely used drug eluting stent available in the U.S. have been consistent and significant across the SPIRIT trials," said Gregg W. Stone, M.D., of Columbia University Medical Center and the Cardiovascular Research Foundation, New York and principal investigator of the SPIRIT III clinical trial. "The robust body of safety and efficacy data support approval of XIENCE V as an important new technology that will enhance the lives of millions of patients with heart disease."

Abbott filed its Premarket Approval (PMA) submission for XIENCE V with the FDA on June 1, 2007. The PMA for XIENCE V is the first to include data demonstrating superiority of one drug eluting stent over another in the primary endpoint of in-segment late loss in a randomized controlled head-to-head trial with a market leading product.

"The outcome of today's advisory committee meeting is very encouraging," said John M. Capek, Ph.D., executive vice president, Medical Products, Abbott. "We look forward to bringing this important new treatment for coronary artery disease to physicians and patients in the U.S."

XIENCE V was launched in Europe and other international markets in 2006. XIENCE V is currently an investigational
'/>"/>

SOURCE Abbott
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Genaera Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436)
2. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
3. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
4. Patient Safety Authority Board of Directors Names Infection Advisory Panel
5. Broker a Suite of Research & Advisory Services to Enhance Human Resources
6. Lynn Clark Callister, National Leader in Maternal-Child Health Nursing, Joins March of Dimes Advisory Council
7. MaxLife Fund Corp. appoints Daniel E. Kahan, to its Advisory Board
8. Delta Dental Plans Association Forms National Scientific Advisory Committee
9. Alter+Care Creates the Advisory Board
10. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
11. Susan G. Komen for the Cure Appoints Dr. Amelie G. Ramirez to Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 22, 2014 Aid in Recovery, a ... statement today regarding a recent bill introduced ... Pagdilao, a current legislator and retired police general. In ... drug related offenders, rather than imprisonment. Aid in Recovery ... forward-thinking solution for the drug addiction epidemic. , The ...
(Date:8/21/2014)... Benefiting from accelerated aging population ... the Chinese orthopedic instrument market demand has been ... of 19.2% during 2009-2013. Trauma products, spine products ... orthopedic instruments in China, of which trauma products ... 2013. , Being optimistic about bright future of ...
(Date:8/21/2014)... (PRWEB) August 22, 2014 The natural loss ... fine lines, wrinkles and sagging of skin. Using products ... "By age 40, the body has lost about 15% of ... about 45%," says Kathy Heshelow, founder of Sublime Beauty®. ... of it - well, we know what happens." , Collagen ...
(Date:8/21/2014)... 21, 2014 Florida Hospital Zephyrhills ... one of the only in the Tampa Bay ... using the Olympus Endoalpha Universal Platform for surgical ... GI endoscopic specialties, and provides the hospital a ... operational efficiencies and patient care. Surgical endoscopy systems, ...
(Date:8/21/2014)... (PRWEB) August 22, 2014 Recently, Skmen.com, a ... new selection of girls’ casual dresses . From ... price (up to 30 percent off) when they are shopping ... company’s new casual outfits are according to the newest quality ... addition to the charming casual dresses, worldwide ladies can also ...
Breaking Medicine News(10 mins):Health News:Proposed Legislature in the Philippines Highlights the Need for Rehabilitation, Not Incarceration, for Drug Users, Says Aid in Recovery 2Health News:Proposed Legislature in the Philippines Highlights the Need for Rehabilitation, Not Incarceration, for Drug Users, Says Aid in Recovery 3Health News:China Orthopedic Instrument Industry Report, 2014-2017 Now Available at ChinaMarketResearchReports.com 2Health News:China Orthopedic Instrument Industry Report, 2014-2017 Now Available at ChinaMarketResearchReports.com 3Health News:China Orthopedic Instrument Industry Report, 2014-2017 Now Available at ChinaMarketResearchReports.com 4Health News:4 Skincare Products That Boost and Nurture Collagen on Sale at Sublime Beauty® 2Health News:4 Skincare Products That Boost and Nurture Collagen on Sale at Sublime Beauty® 3Health News:Florida Hospital Zephyrhills is Elevating Healthcare by Offering the First Olympus Fully-Integrated HD Operating Room in Pasco County 2Health News:Florida Hospital Zephyrhills is Elevating Healthcare by Offering the First Olympus Fully-Integrated HD Operating Room in Pasco County 3Health News:Charming Girls’ Casual Dresses Now Released by Distinguished Garment Company Skmen.com 2
... Randy Dotinga HealthDay Reporter , TUESDAY, July 26 ... more than satisfy our stomachs. They may also soothe our ... fat seems to make us less vulnerable to sad emotions, ... Dr. Lukas Van Oudenhove, co-author of a study that tracked ...
... Amanda Gardner HealthDay Reporter , TUESDAY, July 26 ... in the Medicare Part D prescription drug plan may extend ... Part D participants also seemed to have lower hospital ... has kept them healthier longer. "That effect of ...
... may have an alternative therapy when they develop ... to a laboratory finding published in Clinical ... Association for Cancer Research. Jacek Capala, Ph.D., ... and colleagues designed, produced and tested HER2-Affitoxin, a ...
... of British Columbia have won five-year grants totaling nearly ... (CIHR) to promote greater equity in global health. ... Population and Public Health, received $1.9 million to lead ... food system through five interconnected projects in Ecuador and ...
... July 26, 2011St. Michael,s Hospital today became the first in ... kidney patient that will allow him to receive a transplant ... involving a donor and recipient with different blood types are ... would cause their immune system to reject an organ from ...
... hormone therapy to radiation therapy has been proven in ... with intermediate- and high-risk prostate cancer. However, adding hormone ... heart conditions, even if they have high-risk prostate cancer ... advance of print in the International Journal of ...
Cached Medicine News:Health News:Fatty 'Comfort' Foods May Alter Brain's Response to Sadness 2Health News:Study Finds Savings From Medicare's Drug Plan Extend Beyond Cost of Meds 2Health News:Study Finds Savings From Medicare's Drug Plan Extend Beyond Cost of Meds 3Health News:3 research programs win $6M in CIHR grants to promote global health equity 2Health News:St. Michael's North America first to use novel blood-cleaning procedure for kidney transplant 2Health News:Hormone therapy may be hazardous for men with heart conditions 2
(Date:8/21/2014)... ARMONK , N.Y. and HAMBURG, Germany ... today announced it is collaborating with Deutsches Elektronen-Synchrotron ( ... Germany , to speed up management and ... Big Data and Analytics architecture based on ... gigabyte per second of data at peak performance and ...
(Date:8/21/2014)... YORK , August 21, 2014 ... Israeli subsidiary, BreedIT Ltd., the exclusive worldwide license ... software for plant breeders and researchers, today is ... a joint venture with Seach Ltd, a leading ... formed to research and develop new breeds of ...
(Date:8/21/2014)... , Aug. 21, 2014  Armada Health Care ... organization (GPO), is pleased to announce an agreement ... a host of innovative specialty pharmacy patient program ... enhanced therapy management services to specialty patients via ... Aurora will use the OTM platform ...
Breaking Medicine Technology:DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 4Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 2Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 3
... 27, 2011 DeviceSpace , the leading employment ... 2011-2012 U.S. Device™ Hotbed Campaign this morning, ... United States. (Logo: http://photos.prnewswire.com/prnh/20040907/CLTU006LOGO) Each ... printed campaign map that is promoted online ...
... CHICAGO, June 27, 2011 The American Pain Foundation ... an educational initiative designed to help educate Hispanic Americans ... with pain and their health care providers.  A growing ... less likely to have access to pain management services ...
Cached Medicine Technology:DeviceSpace Campaign Features Medical Device and Diagnostics Companies 2American Pain Foundation Launches New Educational Campaign, "Explain Your Pain," to Help Hispanic Americans Better Understand Chronic Pain and Pain Management 2American Pain Foundation Launches New Educational Campaign, "Explain Your Pain," to Help Hispanic Americans Better Understand Chronic Pain and Pain Management 3
... is an excellent choice to treat arthritic pain, ... or following cast removal. The durable canvas ... and compression to the wrist to help relieve ... splint prevents painful wrist flexion, and holds the ...
... options for controlling range of motion of ... better known for its lower extremity bracing ... of patients have benefitted from our custom ... ,Townsends ROM Series post-operative elbow braces come ...
... Joint Technology" elbow brace has been designed ... help re-establish pain free range of motion. ... engineered to provide the clinician and patient ... Treatment use includes Wrist and Forearm Fractures, ...
Designed to provide comfortable immobilization of the elbow...
Medicine Products: